共 23 条
High-Throughput Screen for Novel Antimicrobials using a Whole Animal Infection Model
被引:159
作者:
Moy, Terence I.
[1
,2
,3
]
Conery, Annie L.
[2
,3
]
Larkins-Ford, Jonah
[2
,3
]
Wu, Gang
[2
,3
]
Mazitschek, Ralph
[4
]
Casadei, Gabriele
[5
]
Lewis, Kim
[5
]
Carpenter, Anne E.
[6
]
Ausubel, Frederick M.
[1
,2
,3
]
机构:
[1] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA
[5] Northeastern Univ, Dept Biol, Boston, MA 02115 USA
[6] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
关键词:
ANTIBACTERIAL DRUG DISCOVERY;
CAENORHABDITIS-ELEGANS;
C-ELEGANS;
INHIBITORS;
BACTERIAL;
ASSAY;
D O I:
10.1021/cb900084v
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The nematode Coenorhabditis elegons is a unique whole animal model system for identifying small molecules with in vivo anti-infective properties. C elegons can be infected with a broad range of human pathogens, including Enterococcus faecalis, an important human nosocomial pathogen. Here, we describe an automated, high-throughput screen of 37,200 compounds and natural product extracts for those that enhance survival of C elegans infected with E faecalis. Using a robot to dispense live, infected animals into 384-well plates and automated microscopy and image analysis, we identified 28 compounds and extracts not previously reported to have antimicrobial properties, including six structural classes that cure infected C elegons animals but do not affect the growth of the pathogen in vitro, thus acting by a mechanism of action distinct from antibiotics currently in clinical use.
引用
收藏
页码:527 / 533
页数:7
相关论文